Hetero, Cipla's Remdesivirs Hit India Market, 'Surplus' Envisaged By August

Prices Well Below $100/vial

 
• By Anju Ghangurde
  
Coins, money and COVID-19 on scale. Concepts of economics against coronavirus. Balancing and managing losses. 3D render
Hetero, Cipla Hit Market With Generic Remdesivir • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from India

More from Focus On Asia